TDP-43

Prothena, Celgene ink neuro R&D pact potentially worth $2B+
Fierce Biotech
Wed, 03/21/18 - 09:20 am
Prothena
Celgene
R&D
TDP-43
anti-tau antibodies
Alzheimer's disease